Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
Conference
2025 AASCIF Annual Conference
Enlyte to Sponsor 2025 AASCIF Annual Conference in New OrleansEnlyte is proud to announce ou
Workers' Comp
Article
Supporting Safer, Smarter Workplaces with Physical Demands Analysis
Understanding the physical demands of a job is critical to making smart decisions about employee health, safety and productivity.
Mitchell
News Release
Strong Sales of New Battery Electric Vehicles Face Tariff Threat
SAN DIEGO, Calif.—Mitchell, a leader in the development of innovative auto phys
Mitchell
Article
Plugged-In: EV Collision Insights Q1 2025
Do
Business Insurancec
In the News
Data shows aging workers driving up comp costs
Workers' Comp
In the News